CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B

CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B

Singh, Vijai

Elsevier Science Publishing Co Inc

01/2025

300

Dura

9780443224201

Pré-lançamento - envio 15 a 20 dias após a sua edição

Descrição não disponível.
Preface
Vijai Singh
1. Current approaches in CRISPR -Cas systems for metabolic disorders
DHRUV KUMAR
2. Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases
Mayank Bansal
3. Recent progress in CRISPR -Cas systems for cataract and blindness
Suresh Ramakrishna
4. Advances in CRISPR -Cas systems for muscular dystrophy
Vancha Harish
5. Recent development in CRISPR -Cas systems for cardiac disease
Xin Wang
6. Current approaches in CRISPR -Cas systems for diabetes
L. Karthik
7. Advances in CRISPR -Cas systems for liver disease
Majid Mojarrad
8. Advances in CRISPR -Cas systems for lung disease
Suresh Ramakrishna
9. Advances in CRISPR -Cas systems for kidney diseases
Anil Bhanudas Gaikwad
10. Current progress in CRISPR -Cas systems for rare disease
Ajay Kumar I
11. Advances in CRISPR -Cas systems for heredity disease
DHRUV KUMAR
12. Recent progress in CRISPR -Cas systems for neurological disorders
Anand Krishna Tiwari
13. CRISPR challenges in clinical developments
Hossein Soltaninejad, Mohadeseh Khoshandam and Saman Hosseinkhani
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Human diseases; metabolic disorders; retinal disease; muscular dystrophy; cardiac disease; diabetes; liver disease; lung disease; neurological disorders